Tirzepatide Semaglutide 910463-68-2 powder 99%
TDS 56 Inquiries
946870-92-4
Pharmaceutical Grade
99%
shenzhen
subi
1mg*l0vials
2025-07-12
peptone
-
Product Description
-
Seller Information
-
Inquiry History
-
DescriptionECHEMI Editorial ReferenceLong arginine 3-IGF-1, abbreviated as IGF-1 LR3 or LR3-IGF-1, is a synthetic protein and lengthened analogue of human insulin-like growth factor 1 (IGF-1). It differs from native IGF-1 in that it possesses an arginine instead of a glutamic acid at the third position in its amino acid sequence ("arginine 3"), and also has an additional 13 amino acids at its N-terminus (MFPAMPLLSLFVN) ("long"), for a total of 83 amino acids (relative to the 70 of IGF-1).Certificates
-
TDS
Basic Info-
Product Name:
IGF-1 LR3
Other Name:IGF-1 LR3;CL281;LR3-IGF1;IGF-1Lr3 Igtropin;LR3-IGF1 (100mcg/vial;IGF LR3-1;IDF-1 LR3;Recombinant Human Insulin-like Growth Factor-1 LR3, rhIGF-1
CAS No.:946870-92-4
Molecular Weight:0
EC Number:1592732-453-0
Categories:
Research-
Class:
Dual agonist — GIPR, GLP-1R
Status:FDA-approved (Mounjaro / Zepbound)
Mechanism:Dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist. A 39-amino-acid modified peptide with a C20 fatty diacid moiety that enables albumin binding for extended half-life (~5 days). Selectively activates both GIPR and GLP-1R signaling pathways.
EC50 (Human GLP1R):0.934 nM
EC50 (Human GIPR):0.0224 nM
Source:Frias JP, et al. N Engl J Med. 2021;385(6):503-515.DOI
Clinical Development:NCT03954834; NCT03987919; NCT03882970; NCT03730662; NCT04039503
FDA:Mounjaro, Zepbound (approved 2022-05-13)
References-
ChEMBL:DrugBank:KEGG DRUG:PubChem:Disclaimer:
Tirzepatide is approved as a prescription medicine (Mounjaro, Zepbound) in certain jurisdictions. This listing is for industrial and laboratory research use only. Research-chemical listings on B2B marketplaces are not interchangeable with approved medicines. Confirm CAS, specification, and regulatory pathway with the seller. It is not medical advice, a clinical recommendation, or an approved therapy description.
-
-
Seller Information
-
Business Type:
Trader
-
Main Products:
peptone
-
Location:
Room A109, No. 29 Dongting Road, Hexi District, Tianjin
-
Payment Terms:
TT against copy of documents
-
Average lead Time:
3
-
Total Annual Revenue:
$2.5 million-$5 million
-
Total Employees:
Less than 5
-
Year of Establishment:
2024
-
-
Inquiry History56 Inquiries
Country Product Purchase Quantity Date Posted
United States
Best price Pure 98% LR3-IGF1 peptide IGF1 LR3 cas 946870-92-4
10 MT May 3, 2026
United States
Wholesale 99% High Purity IGF-1 LR3 Lyophilized Powder CAS 946870-92-4 Factory Direct Supply
10 PCS Apr 9, 2026
France
IGF-1 LR3 High Purity Ig F-Lr3 Peptides Powder CAS 946870-92-4 with Competitive Price
5 Nov 1, 2023
United States
YM 2024 High Quality Wholesale Price Peptides Factory Direct Supply IGF-1LR3 Powder CAS 946870-92-4
1111 MT Dec 18, 2025
Russia
igf-1 lr3
1 G Apr 22, 2025
Russia
Igf Lr3
10 MG Jun 6, 2026
United States
IGF-1 LR3
1 MT May 31, 2026
Canada
IGF-1 LR3
1 MG Mar 15, 2026
United States
IGF-1 LR3
10 MT Feb 23, 2026
United Kingdom
IGF-1 LR3
2 PCS Jan 21, 2026
Brazil
IGF-1 LR3
2 MG Jan 4, 2026
Canada
IGF-1R3
10 Dec 9, 2025
United States
Igf1 lr3
10 G Oct 16, 2024
Croatia
Igf-1 lr3
1 MT Oct 2, 2024
United States
IGF1-LR3
7.5 Feb 11, 2024
United States
IGF-1 LR3 99% powder Pharmacy Grade Top Purity Senwayer
3 MT Sep 18, 2023
Switzerland
IGF-LR3 Recombinant Human IGF-1 LR3 99%
20 Jul 29, 2026
United States
Igf-1lr3
10 MT Jul 20, 2026
United States
IGF-1LR3
1 G Jun 22, 2026
South Korea
igf lr3
10 G Jun 16, 2026 Post an enquiry for this product